Key Takeaways SNA topped Q2 EPS and revenue estimates despite earnings dipping 3.9% y/y. Tools Group sales rose 1.9%, driven by stronger U.S. demand and slight currency gains. The gross margin held at 50.5%, supported by quick-payback products and strategic execution.Snap-on Inc. (SNA) has reported second-quarter 2025 results, wherein the top and bottom lines surpassed the Zacks Consensus Estimate. Meanwhile, earnings declined from the year-ago period and revenues were in line with the prior-year quarter. ...

Core Insights - Abbott Laboratories (ABT) reported second-quarter 2025 adjusted earnings per share (EPS) of $1.26, beating the Zacks Consensus Estimate by 0.8% and improving 10.5% year over year [2][8] - Despite strong earnings and revenue results, ABT stock fell 5% in pre-market trading due to cautious third-quarter guidance [2][8] Revenue Performance - Worldwide sales reached $11.14 billion, a 7.4% increase year over year, surpassing the Zacks Consensus Estimate by 0.6% [3][8] - Organic sales improved by 6.9% year over year, with organic sales excluding COVID-19 rising by 7.5% [3] Segment Analysis - Established Pharmaceuticals segment sales increased by 6.9% on a reported basis to $1.38 billion, with organic sales in emerging markets growing by 8.7% [4] - Medical Devices segment sales rose 13.4% year over year to $5.37 billion, driven by Diabetes Care and Structural Heart products [5][8] - Diabetes Care division reported organic sales growth of 19.6%, with continuous glucose monitors contributing $1.90 billion to total sales [6] - Nutrition sales rose 2.9% year over year to $2.21 billion, with Adult Nutrition benefiting from strong global growth [7] - Diagnostics sales declined 1% year over year to $2.17 billion, impacted by lower COVID-19 testing-related sales [9] Margin and Expense Details - Gross profit increased by 8.9% year over year to $6.29 billion, with gross margin expanding by 79 basis points to 56.4% [9][10] - Selling, general and administration expenses rose 5.3% to $3.09 billion, while research and development expenses increased by 3.9% to $725 million [10] Financial Guidance - For full-year 2025, Abbott expects adjusted diluted EPS in the range of $5.10-$5.20, with organic sales growth projected at 7.5-8.0% [11] - Third-quarter adjusted diluted EPS is expected to be between $1.28 and $1.32, slightly below the Zacks Consensus Estimate of $1.34 [12] Strategic Developments - Abbott announced favorable data from the AVEIR Conduction System Pacing clinical study and received FDA approval for its Tendyne transcatheter mitral valve replacement system [14] - Plans to develop a new cardiovascular device manufacturing facility in Georgia, expected to be completed by 2028 [14]

（图片来源：RealEstate） 买家希望获得最新房源，有些甚至愿意付费给代理，只为获取那些难以得到的非公 开挂牌房源。 据密切监控库存水平的SQM的Louis Christopher称，悉尼有6300套未 售出房源已在市场上挂牌180天以上。 旧房源数量较去年同期增长了30%。 与此同时，6月份的新挂牌房源数量同比下降了 约4%，SQM统计的新挂牌房源为12700套。 在住宅房地产市场分析中，旧房源很少受到重视。 据RealEstate网站报道，尽管被买家和大多数市场分析师忽视，但这些滞销房源在 提升库存水 平和影响价格走向方面产生着重要影响。 悉尼的旧房源数量仍远低于2019年10000套的纪录，当时总挂牌房源达到最高水 平，接近40000套，这为买家提供了大量选择，可能也让他们在谈 判中处于更有利 的地位。 悉尼买家现在有34500套房源可供选择，约18%的库存是滞销房源。 Christopher指出，旧库存的增加表明定价与买家的购买意愿和能力不匹配。 悉 尼"即便在冬季新挂牌房源减少的情况下，仍在应对滞销房源的问题"。 Christopher经常提到，在市场放缓或下行期间，旧房源通常会增加。 显然， ...

Fartcoin looks good hereGeiger Capital (@Geiger_Capital):Fartcoin up +23% today on strong retail sales.Time for the Fed to cut rates. https://t.co/1Yp0wpwjlX ...

Key Takeaways AAR Corp. ((AIR) reported fourth-quarter fiscal 2025 adjusted earnings of $1.16 per share, which surpassed the Zacks Consensus Estimate of $1.00 by 16%. The bottom line also improved 31.8% from the year-ago quarter's level of 88 cents per share. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) The company reported GAAP earnings of 95 cents per share compared with 26 cents in the prior-year quarter. The year-over-year improvement in the bottom line can be attributed to ...

Key Takeaways RTX is set to report Q2 results on July 22, with revenue and EPS estimates showing year-over-year growth. Commercial engine and aftermarket sales likely boosted Pratt & Whitney and Collins Aerospace performance. RTX showcases strong price gains, but trades at a premium and holds lower ROE versus the peer group.RTX Corp. (RTX) is slated to release second-quarter 2025 results on July 22, before the opening bell.  The Zacks Consensus Estimate for revenues is pegged at $20.66 billion, implying 4 ...

there has been a drop off in uh in inbound eur you know demand Europe is one but it's a single-digit decline so and US point of sale has more than made up for it and it's 80% of our business I don't think it'll be permanent um you know the the United States is the greatest country on earth um it's a great place for people to come a great place for people to visit demand is affected by all kinds of things we have fewer students coming to the US right now um you know not surprisingly uh that's a big be fewer ...

Market Overview - Volatility in the U.S. stock market is expected to continue due to uncertainty regarding interest rate cuts, new tariffs, and geopolitical tensions, complicating portfolio management for individual investors [1] Investment Strategy - Selecting inappropriate stocks can negatively affect returns, undermining investment goals; adhering to broker advice is suggested as brokers possess extensive knowledge of stocks and the broader economy [2] Recommended Stocks - Broker-friendly stocks identified for potential healthy returns include BrightSpring Health Services (BTSG), GXO Logistics (GXO), BrightView Holdings (BV), Bloomin' Brands (BLMN), and Archer Daniels Midland Company (ADM) [3][9] Screening Methodology - A screening strategy was developed to identify stocks based on improving broker recommendations and upward revisions in earnings estimates over the past four weeks, incorporating the price/sales ratio as a valuation metric [4] Screening Criteria - The screening criteria include: - Top 75 companies with net upgrades in broker ratings over the last four weeks [5] - Top 10 stocks with positive earnings estimate revisions for the upcoming quarter [5] - Bottom 10% of stocks based on price/sales ratio [5] - Stocks priced above $5 to attract investor interest [5] - Average daily volume exceeding 100,000 shares over the last 20 trading days [6] - Top 3000 stocks by market capitalization [6] Company Highlights - **BrightSpring Health Services (BTSG)**: Expected earnings growth rate of 55.4% for 2025, with a projected revenue increase of 9.1% over 2024; currently holds a Zacks Rank 2 (Buy) [7][9] - **GXO Logistics (GXO)**: Benefits from increased e-commerce and cost-cutting efforts; projected revenue growth of 9.9% for 2025; currently holds a Zacks Rank 3 (Hold) [10][11] - **BrightView Holdings (BV)**: Largest commercial landscaper in the U.S., with expected earnings growth of 10.5% for 2025; currently holds a Zacks Rank 3 [12][13] - **Bloomin' Brands (BLMN)**: Performance driven by off-premise channels and technology upgrades; Zacks Consensus Estimate for 2025 earnings revised upward by 1.7% [14][15] - **Archer Daniels Midland Company (ADM)**: Focus on flexitarian diets and sustainable materials; currently holds a Zacks Rank 3 [16][17]

Swatch Group reports another six months of falling sales and profit, hit hard by sluggish demand for luxury timepieces in China https://t.co/1ddggVwmfW ...

RT AvaCloud (@AvaCloud)A new era has arrived. 🚀@WarpGameCHAIN has recently launched their own L1, powered by @AvaCloud.Coming soon ➡️ They’ll be opening a node license sale - an opportunity for users to help secure and support the network.More details coming soon and be sure to also follow @WarpGameFDN & @WarpGameCTLYST to stay up-to-date. 🔺 ...